CABIO(SH:688089) 第一财经·2026-01-12 03:14Core Viewpoint - The article discusses the recent preventive recall of infant formula by Nestlé due to potential quality risks associated with ARA supplied by Jia Bi You Biotechnology (Wuhan) Co., Ltd. The situation has led to significant stock price declines for Jia Bi You and raised concerns in the market regarding the safety of infant formula products [3][4][5]. Group 1: Company Impact - Jia Bi You, the supplier involved in the recall, received a regulatory notice from the Shanghai Stock Exchange urging timely responses and compliance with information disclosure obligations [3]. - Following the recall announcement, Jia Bi You's stock price opened at 20.2 yuan, reflecting a decline of 1.22%, with a cumulative drop exceeding 16.7% since the incident [5]. - The company has stated that it has sent products for testing and will release results once available [5]. Group 2: Industry Response - Nestlé announced a global recall of certain batches of infant formula across 31 countries due to potential quality risks from ARA, although no disease reports related to the affected raw materials have been confirmed [4]. - The State Council's Food Safety Office and the Market Supervision Administration have emphasized the importance of corporate responsibility and have mandated Nestlé (China) to implement the recall effectively [6]. - Other major infant formula brands in China, including Yili, Mengniu, and others, have issued statements asserting the safety and reliability of their products, distancing themselves from the incident [6].